phosphocol p32
Small moleculeapproved
Approved
Sep 23, 1974
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1970s
- Sep 23, 1974
Curium Pharma — Earliest FDA Approval
- Sep 23, 1974
Curium Pharma — NDA Secondary Org
- Sep 23, 1974
Curium Pharma — NDA Organization
Indications
Approved for
Mechanism of action
- DNABINDING AGENT
DNA binding agent
Approval history
- approvedSep 23, 1974
Chemistry & pharmacology
- Mol. weight
- 147.97 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
- Payload
- 32-Phosphorous
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1200676 ↗
Also known as
- chromic phosphate (32p)
- chromic phosphate (32p)
- chromic phosphate p 32
- chromic phosphate p 32
- chromic phosphate p-32
- chromic phosphate p-32
- chromic phosphate p-32
- chromphosphotope
- chromphosphotope
- phosphocol p32
- phosphocol p32
- phosphocol p32
- phosphorous (32p) chromicphosphate colloid
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Curium Pharma | For profit | NDA2 | Sep 23, 1974 |
| Curium Pharma | For profit | NDA | Sep 23, 1974 |